Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Unnamed
Year:
1999
Reference Type:
publication
Title:
Unnamed
Year:
2000
Reference Type:
publication
Title:
Unnamed
Year:
2002
Reference Type:
review article or handbook
Title:
Contact Sensitisation: Classification According to Potency.
Author:
ECETOC
Year:
2003
Bibliographic source:
Technical Report No. 87, European Centre for Ecotoxicology and Toxicology of Chemicals, Avenue Van Nieuwenhuyse 4, (Bte 6) B-1160 Brussels, Belgium, ISSN-0773-8072-87: 8
Reference Type:
publication
Title:
Unnamed
Year:
2003
Reference Type:
review article or handbook
Title:
Unnamed
Year:
2000

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
now OECD 429 (LLNA local lymph node assay)
Principles of method if other than guideline:
Measurement of lymphocyte proliferative responses that are induced in draining lymph nodes following topical exposure of mice to test substance. An EC3 value is derived; this being the amount of a chemical sensitiser that is required to elicit a 3-fold increase in lymph node cell (LNC) 
proliferative activity.
GLP compliance:
not specified
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
Ethylene dimethacrylate
EC Number:
202-617-2
EC Name:
Ethylene dimethacrylate
Cas Number:
97-90-5
Molecular formula:
C10H14O4
IUPAC Name:
2-[(2-methylprop-2-enoyl)oxy]ethyl 2-methylprop-2-enoate
Details on test material:
Purity not specified, but commercial grade assumed.

In vivo test system

Test animals

Species:
mouse
Strain:
CBA
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: no data
- Age at study initiation: 6 to 16 wk-old
- Weight at study initiation: no data
- Housing: no data
- Diet (e.g. ad libitum): no data
- Water (e.g. ad libitum): no data
- Acclimation period: no data

ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data

Study design: in vivo (LLNA)

Vehicle:
acetone/olive oil (4:1 v/v)
No. of animals per dose:
4 or 5
Details on study design:
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: local lymph node assay (LLNA), standard protocol according to OECD 406
- Criteria used to consider a positive response:
A test material that, at one or more concentrations, causes an stimulation indices (SI) of 3 or greater is considered to have skin-sensitizing activity.

TREATMENT PREPARATION AND ADMINISTRATION:
Groups of mice (n = 4 or 5) are treated by topical a pplication, on the dorsum of both ears, with 25 µL of several concentrations of test material, or with an equal volume of the relevant vehicle alone. They are treated daily for 3 consecutive days, followed by a 2-day rest period before analysis. On the sixth day (5 days after initiation of treatment), the mice are injected intravenously, by the tail vein, with 250 µL of sterile phosphate-buffered saline (PBS) containing 20 µCi of [³H] methyl thymidine. Five hours later, the mice are killed.and the draining auricular lymph nodes are excised and pooled for each experimental group or for each individual animal. Single cell suspensions of lymph node cells are prepared. Lymph node cells are washed twice with an excess of PBS and precipitated with 5% trichloroacetic acid (TCA) at 4°C.The samples, pelleted by centrifugation, are resuspended 12 to 18 hours later in 1 mL of 5% TCA and transferred to 10 mL of scintillation cocktail. lncorporation of tritium­ labeled thymidine [³H-TdR] is measured by beta-scintillation counting and expressed as disintegrations per minute (dpm).
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
mercaptobenzothiazole (CAS No 149-30-4)
other: benzocaine

Results and discussion

In vivo (LLNA)

Results
Key result
Parameter:
EC3
Value:
35
Test group / Remarks:
4 or 5 animals
Remarks on result:
other: extremely weak sensitiser

Any other information on results incl. tables

EC3: 35 % extremely weak sensitiser
EC3 value is the estimated concentration of a chemical necessary to give a 3-fold stimulation of proliferation in lymph nodes compared to concurrent 

vehicle-treated controls.

Applicant's summary and conclusion

Interpretation of results:
Category 1B (indication of skin sensitising potential) based on GHS criteria
Conclusions:
Ethyleneglycol dimethacrylate was found to be a extremely weak sensitiser in the LLNA test according to OECD 406 now OECD 429 (EC3: 35 % ).
Executive summary:

In a dermal sensitization study (standard protocol) with Ethyleneglycol dimethacrylate (purity: no data) dissolved in acetone : olive oil (4 +1) as a vehicle, (4 or 5 animals per dose group) 6 to 16 weeks old female CBA/Ca mice were tested using the method of OECD 406 (now OECD 429 Local Lymph node Assay (LLNA)). 

Groups of mice are treated by topical application, on the dorsum of both ears, with 25 µL of several concentrations of test material, or with an equal volume of the relevant vehicle alone. They are treated daily for 3 consecutive days, followed by a 2-day rest period before analysis. On the sixth day (5 days after initiation of treatment), the mice are injected intravenously, by the tail vein, with 250 µL of sterile phosphate-buffered saline (PBS) containing 20 µCi of [³H] methyl thymidine. Five hours later, the mice are killed.and the draining auricular lymph nodes are excised and pooled for each experimental group or for each individual animal. Single cell suspensions of lymph node cells are prepared. Lymph node cells are washed twice with an excess of PBS and precipitated with 5% trichloroacetic acid (TCA) at 4°C. The samples, pelleted by centrifugation, are resuspended 12 to 18 hours later in 1 mL of 5% TCA and transferred to 10 mL of scintillation cocktail. lncorporation of tritium­ labeled thymidine [³H-TdR] is measured by beta-scintillation counting and expressed as disintegrations per minute (dpm).

The validation-/positive control experiment was performed with alpha-Hexyl cinnamic aldehyde, 2 -mercaptobenzothiazole, and benzocaine.

In this study a Stimulation Indice (S.I.) of EC3: 35% was determined with the test item in acetone : olive oil (4 +1), respectively.

Therefore Ethyleneglycol dimethacrylate was found to be a extremely weak sensitiser in the LLNA test according to OECD 406.